Abstract
6617 Background: Since 2010, the National Cancer Institute (NCI) has taken substantial efforts to compress the timelines for protocol review and trial activation (Abrams, JNCI, 2013). In 2012, NCI’...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have